Login / Signup

Effect of hydrofluoric acid concentration and aging on the bond strength ceramics to a resin cement.

Bruno Delgado ClerotLourenço Correr-SobrinhoMilena BandiniEvaldo Pinheiro Beserra-NetoFernanada Midori TsuzukiRafael Rocha PachecoJúlio César Lemos Duarte
Published in: Brazilian dental journal (2024)
This study evaluated the influence of hydrofluoric acid (HF) concentration and thermal cycling on the microshear bond strength (µSBS) of a resin luting agent to IPS e.max® CAD and Rosetta® SM. Ceramic specimens (12.0 x 14.0 x 1.5mm) were randomized into 8 groups (n=10) according to HF concentration, commercial brand, and aging. Immediately after polishing, and etching, all specimens were silanized and a layer of adhesive was applied. A PVS mold of 3 mm thickness and 10mm diameter with (four) 1.0mm holes was fabricated, placed on each specimen, and then filled with a resin luting agent. Half of the specimens were subjected to the µSBS test using an Instron at a speed of 1.0 mm/min, following a 24-hour storage in deionized water at 37ºC. The remaining specimens were subjected to thermal cycling (5ºC-55ºC, 30 seconds per bath) and µSBS. The data were evaluated utilizing a three-way ANOVA and Tukey's post-hoc test (α=0.05). Significant differences were found for HF concentration and aging (p<0.0001). No significant difference in µSBS was found for commercial brands (p=0.085). The interaction between brand and HF concentration (p=0.358), brand and aging (p=0.135), and HF concentration and aging (p=0.138) were not statistically significant. The triple interaction among these factors was not statistically significant (p=0.610). In conclusion, the bond strength is affected by the HF concentration. No statistical difference was observed between the two ceramics. Thermal cycling significantly reduced µSBS.
Keyphrases
  • acute heart failure
  • high intensity
  • blood pressure
  • clinical trial
  • coronary artery disease
  • heart failure
  • machine learning
  • open label
  • randomized controlled trial
  • atrial fibrillation
  • placebo controlled